Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Preliminary phase I/II data for ZN-c5 monotherapy in ER-positive/HER2-negative breast cancer

Dec. 21, 2020

Korea Pharma describes JAK1 inhibitors

Dec. 21, 2020

Discovery of new PDIA1 inhibitor with antitumor activity in models of multiple myeloma

Dec. 21, 2020

DZD-4205 demonstrates efficacy in phase I/II JACKPOT8 study in PTCL

Dec. 21, 2020

First-in-human data presented for AB-928 with or without IPI-549 in patients with cancer

Dec. 18, 2020

STP-938, a novel CTPS1 inhibitor with activity in hematological malignancies

Dec. 18, 2020

Ideaya Biosciences discloses POLH inhibitors

Dec. 18, 2020

Angex Pharmaceutical presents new PRMT5 inhibitors

Dec. 18, 2020

Agios Pharmaceuticals synthesizes new MAT2A inhibitors

Dec. 18, 2020

VioGen Biosciences patents new PIKfyve inhibitors

Dec. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.